X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma

Clinical and Experimental Immunology

Volumn 169, Issue 3, 2012, Pages 253-262

  Selmi, C ^a,d   Feghali Bostwick, C A ^c   Lleo, A ^a,d   Lombardi, S A ^d   De Santis, M ^d   Cavaciocchi, F ^d   Zammataro, L ^d   Mitchell, M M ^b   Lasalle, J M ^b   Medsger, T ^c   Gershwin, M E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Epigenetics; Genome wide; MeDIP; Systemic autoimmunity

Indexed keywords

ARISTALESS RELATED HOMEOBOX; COILED COIL DOMAIN CONTAINING 22 PROTEIN; DEAD BOX POLYPEPTIDE 26B; DEAD BOX POLYPEPTIDE 3 X LINKED PROTEIN; ECTO NOX DISULFPHIDE THIOL EXCHANGER 2; FAMILY WITH SEQUENCE SIMILARITY 122C; FAMILY WITH SEQUENCE SIMILARITY 127C; HEAT SHOCK TRANSCRIPTION FACTOR FAMILY X LINKED 1; INITIATION FACTOR 2; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN LIKE 2; INTERLEUKIN 6; ISOCITRATE DEHYDROGENASE 3 GAMMA; L ANTIGEN FAMILY MEMBER 3; MYOTUBULARIN 1; PHOSPHOGLYCERATE KINASE; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PROTEIN; RETROTRANSPOSON GAG DOMAIN CONTAINING 4 PROTEIN; SIGNAL SEQUENCE RECEPTOR DELTA; SPERMINE SYNTHASE; SYNOVIAL SARCOMA X BREAKPOINT 2 PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN CONJUGATING ENZYME E2A; UNCLASSIFIED DRUG; UTP14A PROTEIN; V RAF MURINE SARCOMA 3611 VIRAL ONCOGENE HOMOLOG PROTEIN; ZINC FINGER BED TYPE CONTAINING 1 PROTEIN; ZINC FINGER PROTEIN 280C; ZINC FINGER PROTEIN 41;

ADULT; APOPTOSIS; ARTICLE; AUTOSOME; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; MONOZYGOTIC TWINS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROBABILITY; PROMOTER REGION; SCLERODERMA; SIGNAL TRANSDUCTION; TWIN CONCORDANCE; TWIN DISCORDANCE; X CHROMOSOME;

EID: 84864778097     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04621.x     Document Type: Article

References (68)

1. Chighizola C, Shoenfeld Y, Meroni PL. Systemic sclerosis. Introduction. Autoimmun Rev 2011; 10:239-40.
2. Bogdanos DP, Smyk DS, Rigopoulou EI etal. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2012; 38:J156-69.
3. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003; 48:1956-63.
4. Bossini-Castillo L, Martin JE, Broen J etal. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet 2012; 21:926-33.
5. Allanore Y, Saad M, Dieude P etal. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 2011; 7:e1002091.
6. De Santis M, Selmi C. The therapeutic potential of epigenetics in autoimmune diseases. Clin Rev Allergy Immunol 2012; 42:92-101.
7. Meda F, Folci M, Baccarelli A, Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol 2011; 8:226-36.
8. Lu Q, Renaudineau Y, Cha S etal. Epigenetics in autoimmune disorders: highlights of the 10th Sjogren's syndrome symposium. Autoimmun Rev 2010; 9:627-30.
9. Wong AH, Gottesman II, Petronis A. Phenotypic differences in genetically identical organisms: the epigenetic perspective. Hum Mol Genet 2005; 14(Special issue no. 1):R11-8.
10. Fraga MF, Ballestar E, Paz MF etal. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005; 102:10604-9.
11. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2:777-80.
12. Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009; 33:12-6.
13. Invernizzi P, Miozzo M, Selmi C etal. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005; 175:575-8.
14. Ozbalkan Z, Bagislar S, Kiraz S etal. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005; 52:1564-70.
15. Uz E, Loubiere LS, Gadi VK etal. Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol 2008; 34:352-5.
16. Selmi C, Brunetta E, Raimondo MG, Meroni PL. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 2012; 11:A531-7.
17. Kent WJ, Sugnet CW, Furey TS etal. The human genome browser at UCSC. Genome Res 2002; 12:996-1006.
18. Gorlova O, Martin JE, Rueda B etal. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 2011; 7:e1002178.
19. Gourh P, Agarwal SK, Martin E etal. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun 2010; 34:155-62.
20. Ito I, Kawaguchi Y, Kawasaki A etal. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis Rheum 2009; 60:1845-50.
21. Ito I, Kawaguchi Y, Kawasaki A etal. Association of the FAM167A-BLK region with systemic sclerosis. Arthritis Rheum 2010; 62:890-5.
22. Radstake TRDJ, Gorlova O, Rueda B etal. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (vol 42, pg 426, 2010). Nat Genet 2010; 42:426-9.
23. Rueda B, Gourh P, Broen J etal. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann Rheum Dis 2010; 69:700-5.
24. Tsuchiya N, Kawasaki A, Hasegawa M etal. Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann Rheum Dis 2009; 68:1375-6.
25. Zhou XD, Lee JE, Arnett FC etal. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis. A genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum 2009; 60:3807-14.
26. Lei W, Luo Y, Yan K etal. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009; 38:369-74.
27. Wang Y, Fan P-S, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 2006; 54:2271-9.
28. Rakyan VK, Beyan H, Down TA etal. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011; 7:e1002300.
29. Baranzini SE, Mudge J, van Velkinburgh JC etal. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 2010; 464:1351-6.
30. Javierre BM, Fernandez AF, Richter J etal. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010; 20:170-9.
31. Gervin K, Vigeland MD, Mattingsdal M etal. DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet 2012; 8:e1002454.
32. Nikpour M, Stevens WM, Herrick AL, Proudman SM. Epidemiology of systemic sclerosis. Best practice and research. Clin Rheumatol 2010; 24:857-69.
33. Judith GH. Twinning. Lancet 2003; 362:735-43.
34. Olsen NJ, Moore JH, Aune TM. Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells. Arthritis Res Ther 2004; 6:120-8.
35. Bolen CR, Uduman M, Kleinstein SH. Cell subset prediction for blood genomic studies. BMC Bioinformatics 2011; 12:258.
36. Idaghdour Y, Storey JD, Jadallah SJ, Gibson G. A genome-wide gene expression signature of environmental geography in leukocytes of Moroccan amazighs. PLoS Genet 2008; 4:e1000052.
37. Pendergrass SA, Hayes E, Farina G etal. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS ONE 2010; 5:e12106.
38. Duan H, Fleming J, Pritchard DK etal. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008; 58:1465-74.
39. Brown CJ, Carrel L, Willard HF. Expression of genes from the human active and inactive X chromosomes. Am J Hum Genet 1997; 60:1333-43.
40. Coffino P. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2001; 2:188-94.
41. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34:J207-19.
42. de la Cruz J, Kressler D, Linder P. Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem Sci 1999; 24:192-8.
43. Gillespie DE, Berg CA. Homeless is required for RNA localization in Drosophila oogenesis and encodes a new member of the DE-H family of RNA-dependent ATPases. Genes Dev 1995; 9:2495-508.
44. Pal-Bhadra M, Leibovitch BA, Gandhi SG etal. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 2004; 303:669-72.
45. Ranji A, Boris-Lawrie K. RNA helicases: emerging roles in viral replication and the host innate response. RNA Biol 2010; 7:775-87.
46. Soulat D, Burckstummer T, Westermayer S etal. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J 2008; 27:2135-46.
47. Baum H, Davies H, Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 1996; 17:64-70.
48. Kelker M, Kim C, Chueh PJ, Guimont R, Morre DM, Morre DJ. Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion. Biochemistry 2001; 40:7351-4.
49. Svegliati S, Cancello R, Sambo P etal. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005; 280:36474-82.
50. Zilberman D, Gehring M, Tran RK, Ballinger T, Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet 2007; 39:61-9.
51. Zhang X, Yazaki J, Sundaresan A etal. Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell 2006; 126:1189-201.
52. Ball MP, Li JB, Gao Y etal. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 2009; 27:361-8.
53. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007; 315:1141-3.
54. Rauch TA, Wu X, Zhong X, Riggs AD, Pfeifer GP. A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci USA 2009; 106:671-8.
55. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 1995; 270:13757-65.
56. Born TL, Smith DE, Garka KE, Renshaw BR, Bertles JS, Sims JE. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. J Biol Chem 2000; 275:29946-54.
57. Nef S, Fiumelli H, de Castro E, Raes MB, Nef P. Identification of neuronal calcium sensor (NCS-1) possibly involved in the regulation of receptor phosphorylation. J Recept Signal Transduct Res 1995; 15:365-78.
58. Lasser AE, Schultz BC, Beaff D, Bielinski S, Kirschenbaum B. Phenylketonuria and scleroderma. Arch Dermatol 1978; 114:1215-7.
59. Matsuura E, Ohta A, Suematsu R etal. Functional disturbance of the stress-adaptation system in patients with scleroderma. Mod Rheumatol 2011; 21:397-405.
60. Mohamed RH, Nassef AA. Brain magnetic resonance imaging findings in patients with systemic sclerosis. Int J Rheum Dis 2010; 13:61-7.
61. Mohammed RH, Sabry YY, Nasef AA. Brain MRI screening showing evidences of early central nervous system involvement in patients with systemic sclerosis. Rheumatol Int 2011; 31:667-71.
62. Giuliodori G, Fraticelli P, Bartolini M etal. Cognitive and cerebral hemodynamic impairment in scleroderma patients. Eur J Neurol 2009; 16:1285-90.
63. Barnes TC, Anderson ME, Moots RJ. The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol 2011; 2011:721608.
64. Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 2001; 27:140-6.
65. Feghali CA, Bost KL, Boulware DW, Levy LS. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 1992; 19:1207-11.
66. Kondo K, Okada T, Matsui T etal. Establishment and characterization of a human B cell line from the lung tissue of a patient with scleroderma; extraordinary high level of IL-6 secretion by stimulated fibroblasts. Cytokine 2001; 13:220-6.
67. Barnes TC, Spiller DG, Anderson ME, Edwards SW, Moots RJ. Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Ann Rheum Dis 2011; 70:366-72.
68. Fujii H, Hasegawa M, Takehara K, Mukaida N, Sato S. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis. Clin Exp Immunol 2002; 130:548-56.